Ultragenyx Pharmaceutical (RARE) Stock Price, News Analysis - MarketBeat Ultragenyx Pharmaceutical Inc , a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Japan, Europe, and internationally
Ultragenyx Pharmaceutical Inc (RARE) Stock Price News - Google Get the latest Ultragenyx Pharmaceutical Inc (RARE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions
Ultragenyx Pharmaceutical (RARE) Stock Price Overview Analyst Forecast According to 17 analysts, the average rating for RARE stock is "Strong Buy " The 12-month stock price forecast is $92 29, which is an increase of 146 04% from the latest price
RARE Stock Price Quote | Morningstar See the latest Ultragenyx Pharmaceutical Inc stock price (RARE:XNAS), related news, valuation, dividends and more to help you make your investing decisions
Ultragenyx Pharmaceutical - RARE - Stock Price Today - Zacks View Ultragenyx Pharmaceutical Inc RARE investment stock information Get the latest Ultragenyx Pharmaceutical Inc RARE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more
Ultragenyx Pharmaceutical Inc. Common Stock (RARE) - Nasdaq Discover real-time Ultragenyx Pharmaceutical Inc Common Stock (RARE) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions Stay ahead with Nasdaq
RARE. O - | Stock Price Latest News | Reuters Get Ultragenyx Pharmaceutical Inc (RARE O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments